99% APIXabanS 503612 - 473612 - 47 - 3 - 3 -

Kākau pōkole:

Kāheaʻia:APIXAHBAN
ʻO ka inoa'ē aʻe:1 - (4 - mybauxyponyl) - 7 - KAKAHI - 4 - T] - Kikowaena - 1 - (4 - myhoxyfonyl) - 7 - kawai - 6 - ninoopsiperidin - (2 - niko - (2.
5 - Luko'keipa [3,4 - KA] Pyridine - 3 - Cakexime
Palapala NO .:503612 - 47 - 3
Marigy:99% min
Formula:Maladdh15n5n
Molele mollecular:459.50
Nā waiwai waiwai:ʻO APIXABAN kahi papa keʻokeʻo keʻokeʻo keʻokeʻo. Heʻano hou o ka oral xa factory inhibitor, aʻo kona inoa kālepa he Eliquinis. Hoʻohanaʻiaʻo Apixabaman e mālama i nā maʻi maʻi e pili ana i nā maʻi maʻi uila a iʻole ke kīwī i ke kīwī e pale aku ai i ka hana Venoous

Hoʻouna i ka leka uila iā mākou

Huahana kikoʻipiop

Nā Kūlana Huakaʻi

Kaoaohai

Mea	Kū-starder
Helehelena	Keʻokeʻo e pio ai - keʻokeʻo keʻokeʻo
ʻO Menu ka hoʻomaʻemaʻe	≥ 99%

Noi

ʻO APIXABAN kahiʻano hou o ke anticoagulant hou, kahiʻano hou o ka oral factor xa inohibitor, kahi i hoʻohanaʻia a mālama i nā pahu koko.
ʻO APIXababa kahi mea hou o Oral Vaintior hou i hoʻokumuʻia e Bristol -ʻO kaʻu Squibb a me PFIZER. Ma ka hoʻopaʻaʻana i kahi overition koʻikoʻi nui xa, e pale i ka aphixaban e pale i ka hanauna thrombin a me ka thrombosis.

Ma ka lā 26ʻApelila 2007, Bristol - Ua hoʻolahaʻiaʻo MyRs Squibb a me PFIZER i kahi hoʻolālā o ka ACOCTOL.
I Mei 2011
No Nowemapa 20,
ʻO ka meaʻaiʻo Kanada a me nā lāʻau lapaʻau,ʻo Iapana, a me ka Dolch a me nā mea hoʻokele waiwai a me nā mea kūʻai akuʻo Grooke.
IʻApelila 12, 2013, Eliniis (APIXABAN), ua hoʻolaha nuiʻia ma ka mākeke ma Kina. ʻO Apixaban kahi hua'ōlelo o Oral Oral ORL OLSOBITOR no ka paleʻana o Venos ThromboMolism (VTE) i nā maʻi maʻi maʻi. Hāʻawiʻo ia i kahi koho palekana a palekana hou no ka AnTicoagulation ma hope o ka hoʻomaʻamaʻaʻana o nā mea maʻi maʻi ma keʻano he clinical.
Ua hōʻoiaʻia nā haʻawina lapaʻau e hoʻohālikelikeʻia me 40 mg subcutaneous i ka wā o ko ka lā he nui,ʻaʻole e hoʻonui i ka hikiʻana o ka cones i ka lā.